Eric S. Langer, president and managing partner at BioPlan Associates, Inc. (Rockville, MD) has joined the Editorial Advisory Board of BioPharm International.
Eric S. Langer, president and managing partner at BioPlan Associates, Inc. (Rockville, MD) has joined the Editorial Advisory Board of BioPharm International.
Langer has more than 20 years’ experience in biotechnology and the life sciences, focused on international marketing management, market assessment, and publishing. He has published, edited, and authored numerous books, reports, and major studies about the industry, on topics such as: advances in biopharmaceutical technology in China, advances in large-scale biopharmaceutical manufacturing, biopharmaceuticals in the US market, cell culture, media, DNA/PCR purification, and many others. Langer teaches at Johns Hopkins University and American University and has developed numerous courses, classes, and seminar programs, including Marketing in a Regulated Environment, Marketing Technical Products, and TechniManagement. In 1989, Langer co-founded BioPlan Associates, Inc. a biotechnology and life sciences marketing company.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.